InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Puhlmann Markus. Director active across 1 company, notably Perspective Therapeutics, Inc.. Aggregated, 2 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €162k. History available since 15 December 2023. The latest transaction was disclosed on 24 January 2024 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations